2001•The Chinese Journal of Clinical PharmacologyRequires access

Study on Bioequivalence of Flunarizine Capsules in Healthy Volunteers

Yu Liu

Open publisher page 0 citations

Abstract

A single administration of 20mg domestic and reference flunarizine capsules were given to two group of 20 healthy male volunteers in randomized crossover study respectively. A high performance liquid chromatographic assay with fluorimetric detection was developed to determine the concentration of flunarizine in human serum. The data were analyzed by 3P97 program. The pharmacokinetics parameters after a single oral administration of 20mg domestic and reference products were as follows: Cmax54.75±14.52μg.L-(-1)and 52.20±13.04μg.L-(-1);tmax2.40±0.45 h and 2.33±0.44h; AUC_(0-24)256.56±42.32μg.L-(-1).hand 248.81±37.43μg.h.L-(-1); AUC_(0-∞)275.87± 45.62μg.h.L-(-1)and 267.48±40.10μg.h.L-(-1);respectively. Variance analysis and two one-sided test were performed to palameters: Cmax AUC_(0-24)andAUC_(0-∞)There was no significant difference. The two preparations were of bioequivalence, the relative bioavailabilities of single oral administration group was 103.29±9.36%.

About this research paper

What this paper is about

A single administration of 20mg domestic and reference flunarizine capsules were given to two group of 20 healthy male volunteers in randomized crossover study respectively. A high performance liquid chromatographic assay with fluorimetric detection was developed to determine the concentration of flunarizine in human serum. The data were analyzed by 3P97 program. The pharmacokinetics parameters after a single oral administration of 20mg domestic and reference products were as follows: Cmax54.75±14.52μg.L-(-1)and 52.20±13.04μg.L-(-1);tmax2.40±0.45 h and 2.33±0.44h; AUC_(0-24)256.56±42.32μg.L-(-1).hand 248.81±37.43μg.h.L-(-1); AUC_(0-∞)275.87± 45.62μg.h.L-(-1)and 267.48±40.10μg.h.L-(-1);respectively. Variance analysis and two one-sided test were performed to palameters: Cmax AUC_(0-24)andAUC_(0-∞)There was no significant difference. The two preparations were of bioequivalence, the relative bioavailabilities of single oral administration group was 103.29±9.36%.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A single administration of 20mg domestic and reference flunarizine capsules were given to two group of 20 healthy male volunteers in randomized crossover study respectively. A high performance liquid chromatographic assay with fluorimetric detection was developed to determine the concentration of flunarizine in human serum. The data were analyzed by 3P97 program. The pharmacokinetics parameters after a single oral administration of 20mg domestic and reference products were as follows: Cmax54.75±14.52μg.L-(-1)and 52.20±13.04μg.L-(-1);tmax2.40±0.45 h and 2.33±0.44h; AUC_(0-24)256.56±42.32μg.L-(-1).hand 248.81±37.43μg.h.L-(-1); AUC_(0-∞)275.87± 45.62μg.h.L-(-1)and 267.48±40.10μg.h.L-(-1);respectively. Variance analysis and two one-sided test were performed to palameters: Cmax AUC_(0-24)andAUC_(0-∞)There was no significant difference. The two preparations were of bioequivalence, the relative bioavailabilities of single oral administration group was 103.29±9.36%.

Key concepts: Bioequivalence, Cmax, Pharmacokinetics, Crossover study, Flunarizine, Pharmacology, Oral administration, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Bioequivalence of Flunarizine Capsules in Healthy Volunteers — Research Paper | ScholarLens